:::回首頁English網站導覽常見問答聯絡我們FB粉絲專頁  
本院簡介 研究單位 技術移轉 研究資源 圖書館 訊息公告 院內網站
 
::: 首頁>
* * *
*
 
Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR211: a peripheral CB1 receptor antagonist”(2018/12/17)

 

Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR211: a peripheral CB1 receptor antagonist

Date: 2018.12.17

1.         Title:

NHRI technology, “DBPR211: a peripheral CB1 receptor antagonist” (abbreviated as “The Technology”) available for industry-academia collaboration or technology licensing.

2.         Description:

Cannabinoid receptor 1 (CB1) is expressed in several peripheral tissues related to metabolic control and its dysregulation contributes to metabolic disorders. DBPR211 is a highly selective antagonist of peripheral CB1 receptors. It exhibits beneficial effects in treating insulin resistance​, obesity and non-alcoholic fatty liver disease. This unique mechanism may potentially render DBPR211 as a highly competitive first-in-class drug candidate for the treatment of type 2 diabetes, obesity and non-alcoholic fatty liver disease.

3.         Potential collaboration partner qualifications:

 

(1)     be incorporated and approved by law and does not have any record of misconduct or conviction for any offense

(2)     better to have related experience and skills for developing The Technology

(3)     better to have experience of international collaboration and clinical trial

(4)     be willing to provide long-term investment

4.         Registration

Please contact to Mr. Hua-Hsuan Liang (Address: Technology Transfer and Incubation Center, National Health Research Institutes, 35 Keyan Road, Zhunan Town, Miaoli County 35053, Taiwan, R.O.C., Tel: +88637-246166#33206, E-mail: huahsuan@nhri.org.tw).

5.         Other:

If The Technology has been exclusively licensed, this announcement will automatically invalid. For detailed status of The Technology, please contact to the case officer.

 

Attachments:

I: Announcement

II: Technology Transfer Vendor Qualification Form

III: Industry-Academia Collaboration Proposal


 

回上一層

 

*
* * *
     
  政策與免責聲明 | 財團法人國家衛生研究院版權所有
竹南院區:苗栗縣竹南鎮 35053 科研路35號 -- 電話: +886-37-206-166
台北辦事處:台北市南港區 11503 園區街3號10樓(南港軟體園區F棟) -- 電話: +886-2-2653-4401
台南院區:台南市北區 70456 勝利路367號(統一健康研究大樓) -- 電話: +886-6-700-0123
各單位分機代表號
電子信箱:webmaster@nhri.org.tw
FB粉絲專頁:財團法人國家衛生研究院@NHRI.TW